Skip to main content
. 2024 Dec 18;25:452. doi: 10.1186/s12882-024-03886-3

Table 2.

Comparison of the mean score of the PLNS and its dimensions between the study groups

Variables Time of measurement Control
Mean ± SD
Intervention
Mean ± SD
P-value
-Medication T1 26.20 ± 4.85 27.11 ± 4.97 0.34*
T2 26.14 ± 4.93 15.92 ± 5.70 < 0.001**
T3 26.02 ± 4.87 18.69 ± 6.04 < 0.001**
P-value > 0.05*** < 0.05***
-Activities of living T1 19.23 ± 4.03 18.55 ± 4.85 0.44*
T2 19 ± 4.12 10.44 ± 3.61 < 0.001**
T3 19.16 ± 4.18 11.36 ± 3.73 < 0.001**
P-value > 0.05*** < 0.05***
-Community and follow-up T1 17.60 ± 1.56 17.41 ± 1.51 0.47*
T2 17.37 ± 1.60 11.02 ± 1.78 < 0.001**
T3 17.51 ± 1.81 11.86 ± 1.58 < 0.001**
P-value > 0.05*** < 0.05***
-Feelings related to condition T1 12.23 ± 2.11 12.25 ± 1.76 0.96*
T2 12.06 ± 2.16 7.98 ± 1.61 < 0.001**
T3 12.08 ± 2.15 8.53 ± 1.44 < 0.001**
P-value > 0.05*** < 0.05***
-Treatment and complications T1 28.21 ± 3.37 28.59 ± 3.82 0.6*
T2 28.18 ± 3.29 16.02 ± 3.83 < 0.001**
T3 28.16 ± 3.43 19.04 ± 4.05 < 0.001**
P-value > 0.05*** < 0.05***
-Enhancing QoL T1 23.18 ± 5.33 22.51 ± 3.41 0.45*
T2 22.82 ± 5.38 13.18 ± 3.20 < 0.001**
T3 22.86 ± 5.33 14.79 ± 3.30 < 0.001**
P-value > 0.05*** < 0.05***
-Skin care T1 10.57 ± 2.68 11.67 ± 3.11 0.06*
T2 10.45 ± 2.75 6.71 ± 2.24 < 0.001**
T3 10.51 ± 2.70 7.37 ± 2.39 < 0.001**
P-value > 0.05*** < 0.05***
Total PLNS T1 137.23 ± 15.82 138.10 ± 13.48 0.77*
T2 136.02 ± 15.97 81.28 ± 15.20 < 0.001**
T3 136 ± 16.03 91.65 ± 15.21 < 0.001**
P-value > 0.05*** < 0.05***

SD = Standard deviation, QoL = Quality of life, PLNS = Patient learning needs

T1: pre-test, T2: Immediately after the intervention, T3: three months after the intervention

* Independent sample t-test

** ANOVA test

*** Repeated measures ANOVA